Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 153Lung Neoplasms 73Pancreatic Neoplasms 44Neoplasms 27Neoplasm Metastasis 25Head and Neck Neoplasms 23Brain Neoplasms 21Breast Neoplasms 18Glioblastoma 15Adenocarcinoma of Lung 15Squamous Cell Carcinoma of Head and Neck 14Gliosarcoma 14Adenocarcinoma, Bronchiolo-Alveolar 11Colorectal Neoplasms 10Glioma 9Carcinoma, Squamous Cell 8Carcinoma, Hepatocellular 8Adenocarcinoma 7Rectal Neoplasms 6Prostatic Neoplasms 6Esophageal Neoplasms 6Central Nervous System Neoplasms 6Carcinoma, Renal Cell 6Astrocytoma 6Oligodendroglioma 5Liver Neoplasms 5Colonic Neoplasms 5Carcinoma 5Recurrence 4Ovarian Neoplasms 4

Interventions

Cetuximab 5pembrolizumab 3Paclitaxel 3Docetaxel 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2Nivolumab 2Cyclophosphamide 2Cisplatin 2Carboplatin 2temsirolimus 1poly ICLC 1fludarabine phosphate 1fludarabine 1abemaciclib 1Vorinostat 1Taxes 1Sorafenib 1Risk Factors 1Ribavirin 1Radiosurgery 1Radiation 1Pemetrexed 1Oxaliplatin 1Nimorazole 1Mitomycins 1Mitomycin 1Jogging 1Injections 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Squamous Cell × Erlotinib Hydrochloride × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡